跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MIDAZOLAM INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MIDAZOLAM INJECTION USP
Authorized
STANDARD
MIDAZOLAM INJECTION USP
sterinova inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
afd1f20fe7bd983e
Company
sterinova inc.
Type
Standard
Approval Details
Approval Id
afd1f20fe7bd983e
Drug Approval Canada Name
MIDAZOLAM INJECTION USP
Product Name
MIDAZOLAM INJECTION USP
Status
Marketed
Status Date
2020-10-26
Original Market Date
2020-10-26
Din
02498022
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Targeted (CDSA IV)
Atc Original
N05CD08 MIDAZOLAM
Atc Name
n 05 cd 08
Aig Number
0119935002
Company Name
sterinova inc.
Company Address
3005 Avenue Jose-Maria Rosell, Saint-Hyacinthe, Quebec, Canada, J2S 0J9
Active Ingredients
MIDAZOLAM
1 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
afd1f20fe7bd983e
Type
Standard
Back to Health Canada Approvals